A lower MOQ offers flexibility for smaller businesses or testing market response, while volume discounts impact profitability at scale
With 12 million people in the UK qualifying for prescription GLP-1 medications, this partnership addresses the growing demand in the market by offering a holistic model of care to those currently on, or considering, GLP-1 medication
A pilot study demonstrated that oral administration of glutathione resulted in decreased levels of alanine aminotransferase (ALT), a key enzyme that serves as a marker of liver inflammation and damage
Ipamorelin, a pentapeptide made up of five amino acids, acts as a selective agonist of the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHS-R)
The approach is realistic, sustainable and non-judgemental
Since different GLP-1s can affect people differently, its important to work with your provider to explore options and find the best fit for your needs